Elkem (ELK) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Q4 2024 EBITDA was NOK 1,161 million with a 14% margin, up 84% year-over-year, driven by Silicones' best result since Q3 2022 and strong Carbon Solutions performance.
Strategic review of the Silicones division initiated, reclassifying it as discontinued operations and assets held for sale to streamline the group and accelerate growth in Silicon Products and Carbon Solutions.
Improvement and capex reduction programmes exceeded targets, delivering NOK 1.7 billion in realized effects and reducing capex by NOK 2.2 billion in 2024.
Board proposed a dividend of NOK 0.30 per share, subject to AGM approval.
Total operating income for Q4 2024 was NOK 8,498 million, up 5% year-over-year.
Financial highlights
EBITDA for Q4 2024 was NOK 1,161 million, up from NOK 632 million in Q4 2023, with all divisions reporting improved EBITDA year-over-year.
EPS for Q4 2024 was NOK -0.03; full-year EPS was NOK 0.77.
Net interest-bearing debt at year-end was NOK 10.3 billion; leverage ratio at 2.5x EBITDA.
Cash flow from operations for Q4 2024 was NOK 318 million; full year NOK 1,484 million.
Equity ratio at year-end was 49%.
Outlook and guidance
Improvement initiatives expected to continue benefiting results in Q1 2025, but markets remain highly uncertain.
Silicones markets expected to remain stable, with benefits from new capacity in China and France, but Q1 2025 will be impacted by Chinese New Year and maintenance.
Silicon Products to benefit from strong cost positions but will curtail production in Iceland and Norway due to power and maintenance.
Carbon Solutions to maintain stable earnings, but Q1 2025 sales volume will be lower due to customer capacity reductions.
Latest events from Elkem
- All agenda items, including the Bluestar share deal and capital decrease, were approved.ELK
EGM 20269 Mar 2026 - Silicones division sale to Bluestar and weak Q4 2025 results mark a major transformation.ELK
Q4 202513 Feb 2026 - EBITDA stable at NOK 1,030m; net profit up on tax assets, Silicones improved despite weak demand.ELK
Q2 20243 Feb 2026 - EBITDA hit NOK 1,235 million, up 131% year-over-year, driven by Silicones and cost programs.ELK
Q3 202418 Jan 2026 - Strong financial performance and strategic investments drive sustainable growth.ELK
SEB Nordic Seminar presentation14 Jan 2026 - 2024 saw strong financials, strategic portfolio review, and top-tier ESG achievements.ELK
DNB Small & Medium Enterprises Conference presentation14 Jan 2026 - Stable results amid weak markets, with Silicones improving and strategic review ongoing.ELK
Lunch presentation14 Jan 2026 - Divesting Silicones to focus on core growth, backed by strong financials and global leadership.ELK
SEB Nordic Seminar presentation14 Jan 2026 - EBITDA up 25% to NOK 898m as Silicones review advances amid market uncertainty.ELK
Q1 202528 Nov 2025